Alerts will be sent to your verified email
Verify EmailSAKAR
Sakar Healthcare
|
Gufic Biosciences
|
Caplin Point Lab
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
9.28 % | 25.05 % | 19.84 % |
5yr average Equity Multiplier
|
1.75 | 2.22 | 1.15 |
5yr Average Asset Turnover Ratio
|
0.5 | 1.05 | 0.68 |
5yr Avg Net Profit Margin
|
10.38 % | 10.9 % | 25.35 % |
Price to Book
|
2.68 | 6.16 | 6.25 |
P/E
|
38.7 | 59.89 | 31.54 |
5yr Avg Cash Conversion Cycle
|
-14.29 Days | 26.94 Days | 70.68 Days |
Inventory Days
|
46.75 Days | 66.86 Days | 66.07 Days |
Days Receivable
|
51.16 Days | 128.09 Days | 110.7 Days |
Days Payable
|
103.34 Days | 163.91 Days | 85.23 Days |
5yr Average Interest Coverage Ratio
|
5.43 | 13.1 | 633.04 |
5yr Avg ROCE
|
10.08 % | 27.25 % | 24.45 % |
5yr Avg Operating Profit Margin
|
24.06 % | 18.45 % | 31.52 % |
5 yr average Debt to Equity
|
0.47 | 0.51 | 0.0 |
5yr CAGR Net Profit
|
3.94 % | 14.26 % | 17.23 % |
5yr Average Return on Assets
|
5.37 % | 11.52 % | 17.23 % |
Shareholdings
|
|||
Promoter Holding
|
52.86 % | 72.52 % | 70.56 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-14.68 % | -2.48 % | 1.68 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 2.35 % | 0.87 % |
Sakar Healthcare
|
Gufic Biosciences
|
Caplin Point Lab
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Therapeutic Area Wise Break-Up - API'S
|
Therapeutic Area Wise Break-Up - API'S
|
-
|
-
|